Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-10-057870

Options or other derivatives

  • Director bought 1,707,500 shares at $512,250.00 ($874,666,875,000)
  • Director acquired 341,498 shares (grant or award)
  • Director returned 100,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

JONES DAVID B · Director

Table II: Derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2010-11-03 Returned to the company : show line 1 in the form Common Stock Warrant −50,000 50,000 I
2010-11-03 Returned to the company : show line 2 in the form Common Stock Warrant −50,000 50,000 I
2010-11-03 Grant or award : show line 3 in the form Common Stock Warrant +85,854 85,854 I
2010-11-03 Grant or award : show line 4 in the form Common Stock Warrant +85,854 85,854 I
2010-11-03 Grant or award : show line 5 in the form Common Stock Warrant +84,895 84,895 I
2010-11-03 Grant or award : show line 6 in the form Common Stock Warrant +84,895 84,895 I
2010-11-03 Purchase : show line 7 in the form Call Option (Right to Buy) +1,707,500 $512,250.00 $874,666,875,000 1,707,500 I
Loading xslF345X03/v200822_ex.xml…